Deta-Elis DETA-AP-20, Manuallines, Page: 8 / 60

6
many diseases of infectious nature. The clinical eff ectiveness of
“DETA-AP-20” medical device as monotherapy is comparable
with, and in many cases exceeds, multi-component drug ther-
apy, which allows fast, pronounced and complete recovery
of many hard-to-treat diseases. The use of specially selected
programs of electromagnetic therapy signifi cantly reduces
symptoms and reduces the likelihood of complications. The
“DETA-AP-20” treatment device is compatible with all known
therapy methods. It can reduce the use of drugs in complex
use of the device with the latter. The application of electro-
magnetic therapy may provide invaluable assistance in the
event of contraindications to medical therapy, such as aller-
gies, for example. There are currently no portable electromag-
netic therapy devices similar to “DETA-AP” that implement Rife
methodology.
The creating of the “DETA-AP” electromagnetic therapy
medical device opens up new possibilities in the treatment and
physiotherapy of complex pathologies, and for the fi rst time
places the method on a par with modern highly therapeutic
techniques.
The application of the “DETA-AP-20” device has no contra-
indications and can be used in adults and children, from birth,
subject to observation of treatment methods.
Medical device “DETA-AP-20” can be programed with any
twenty of the 1,500 available treatment programs. As a result
of statistical analysis, the most common and most aggressive
pathogens were selected for the starter set.